DroneShield's RfRecon Bet Faces Its Sternest Test as Institutional Bulls and Bears Collide

DroneShield's revenue jumps 74% to A$125.8M, but net loss widens to A$32.2M; RfRecon launch and short interest create uncertainty.

The most striking thing about DroneShield right now isn't the numbers — it's the company the stock keeps. In early August, Citigroup disclosed a stake of more than five percent in the Australian counter-drone specialist, just days after JPMorgan Chase had topped up its own position. Around the same time, the Australian Securities and Investments Commission (ASIC) recorded DroneShield as briefly the most heavily shorted stock on the entire Australian exchange. Two of Wall Street's biggest institutions and a swarm of short sellers are now betting in opposite directions on the same equity, a divergence that says more about the uncertainty surrounding the company than any single earnings print.

That uncertainty was on full display in the half-year results released last Saturday. Revenue climbed to A$125.8 million, a 74 percent jump year-on-year, yet the bottom line told a different story: a net loss after tax of A$32.2 million and an underlying EBITDA loss of A$12.4 million. The shares initially dipped on the release before recovering to trade about 1.5 percent higher. At Friday's close of €1.08, the stock sits roughly 18 percent below its 50-day moving average of €1.32 — a technical signal that the recent bounce lacks conviction.

What investors are really trying to gauge is whether growth can turn into profit. The company's answer, at least in part, is RfRecon, a portable reconnaissance system built on the RfAI-3 architecture that launched in August and is slated to generate its first sales in the second half. The product is meant to broaden DroneShield's revenue base beyond its traditional counter-drone business into civilian government and commercial markets, which media reports currently peg at around 15 percent of sales. Whether RfRecon can meaningfully lift that share will determine if the company can evolve from a project-driven operation into one with more stable earnings pillars.

There are reasons for optimism. DroneShield confirmed its full-year guidance of A$250 million to A$270 million in revenue, underpinned by committed revenue of A$240 million as of August 21 — with A$43 million of that already earmarked for fiscal 2027 and beyond. That visibility extends past the current outlook and gives management breathing room. So does the balance sheet: A$180 million in cash and zero debt provides a cushion to absorb delays as the company invests heavily in production capacity.

But the bear case is equally straightforward. The net loss of A$32.2 million shows growth is being bought at a steep price, and recurring revenue in the first half amounted to just A$11.5 million — a small sliver of the total. If RfRecon stumbles in its ramp-up, or if the conversion of committed revenue into billings slows, the market could start weighting profitability concerns more heavily than top-line momentum. The stock has already fallen 39 percent since the start of the year and trades roughly 71 percent below its 52-week high of €3.79, a gap that reflects how much investor confidence has eroded.

The presence of heavy short interest complicates the picture further. Short sellers can generate additional selling pressure as long as the fundamental picture remains murky, which may explain why positive news — including the Citigroup and JPMorgan accumulations — has failed to spark a sustained rally. Yet the banks' actions suggest at least part of the institutional community views the current weakness as an opportunity rather than a warning sign.

The coming months will settle the argument. If RfRecon delivers its promised first sales in the second half and the committed revenue converts as planned, the growth narrative holds — even if losses persist for now. If execution slips, whether through delayed deliveries or softer-than-expected demand for the new product, the skepticism already baked into the share price will likely deepen. The first concrete test arrives with RfRecon's initial sales figures, which will show whether the product can genuinely diversify the business or remains a promise waiting to be kept.